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Laszlo Nagy,1,7 Hung-Ying Kao,1,7 associated with the inhibition of the physiologic re-
sponse. Indeed, the thyroid hormone receptor is con-Debabrata Chakravarti,1,7 Richard J. Lin,1,3
verted to an oncogene by mutations that block hormoneChristian A. Hassig,5 Donald E. Ayer,6
binding and create a constitutive transcriptional repres-Stuart L. Schreiber,4,5 and Ronald M. Evans1,2
sor (Graf and Beug, 1983; Damm et al., 1987, 1989; Sap1The Salk Institute for Biological Studies
et al., 1989). Multiple studies on transcriptional silencing2Howard Hughes Medical Institute
by v-ErbA and the nonliganded thyroid hormone recep-La Jolla, California 92037
tor suggest that repression is required for oncogenesis3Graduate Program in Molecular Pathology
and that this process is mediated by a diffusible cofac-University of California at San Diego School of Medicine
tor(s) that associates with the ligand binding domainLa Jolla, California 92093
(LBD) (Casanova et al., 1994; Baniahmad et al., 1995).4Howard Hughes Medical Institute
We and others have identified transcriptional core-5Harvard University
pressors (SMRT and N-CoR) that associate with nonli-Department of Chemistry and Chemical Biology
ganded receptors resulting in suppression of basal tran-Cambridge, Massachusetts 02138
scriptional activity (Chen and Evans, 1995; HoÈ rlein et6Huntsman Cancer Institute
al., 1995; Chen et al., 1996; Sande and Privalsky, 1996).Deparment of Oncological Sciences
While the mechanism of this repression is not known,University of Utah
it could conceptually involve competition for limitingSalt Lake City, Utah 84112
factors, displacement of positive factors, or the genera-
tion of a chromatin structure that limits promoter acces-
sibility.Summary
Chromatin remodeling has long been suggested to
be a critical component of transcriptional regulation (forThe transcriptional corepressors SMRT and N-CoR
review see Felsenfeld, 1996; Wolffe and Pruss, 1996),function as silencing mediators for retinoidand thyroid
and it has been suggested that specific transcriptionalhormone receptors. Here we show that SMRT and
activation may be involved in local changes in chromatinN-CoR directly interact with mSin3A, a corepressor
structure. We and others have demonstrated that nu-for the Mad±Max heterodimer and a homolog of the
clear hormone receptors may utilize the CREB-bindingyeast global±transcriptional repressor Sin3p. In addi-
protein (CBP) or its homolog, p300 (Janknecht andtion, we demonstrate that the recently characterized
Hunter, 1996), to function as a nuclear receptor cofactorhistone deacetylase 1 (HDAC1) interacts with Sin3A
(Chakravarti et al., 1996; Hanstein et al., 1996; Kamei etand SMRT to form a multisubunit repressor complex.
al., 1996; Yao et al., 1996). In addition to CBP/p300,Consistent with this model, we find that HDAC inhibi-
multiple hormone±dependent and ±independent associ-tors synergize with retinoic acid to stimulate hormone-
ated cofactors have been characterized (Fondell et al.,responsive genes and differentiation of myeloid leuke-
1996). Of particular interest is the recent demonstrationmia (HL-60) cells. This work establishes a convergence
that CPB/p300 associates with the histone acetylaseof repression pathways for bHLH-Zip proteins and nu-
P/CAF (Yang et al., 1996b), which displays significantclear receptors and suggests this type of regulation
sequence homology to the yeast transcription activatormay be more widely conserved than previously sus-
Gcn5p, also known to be a histone acetylase (Brownellpected.
et al., 1996). Furthermore, CBP/p300 harbors intrinsic
histone acetyltransferase activity, resulting in alternative
Introduction
or perhaps simultaneous histone acetylation (Ogryzko
et al., 1996). The notion that multiple transcriptional co-
The actions of steroids, retinoids, and thyroid hormones
activators possess acetylase activity suggests that their
are mediated by intracellular nuclear receptors whose recruitment to a DNA template would locally destabilize
coordinate activity defines the physiological response nucleosomes, creating a permissive state for promoter
(Mangelsdorf and Evans, 1995). These receptors are all activation.
structurally related and constitute a superfamily of nu- With this view in mind, it is reasonable to speculate
clear regulatory proteins that modulate gene expression that reversal of transcriptional activation might in part be
in a ligand-dependent fashion. Previous studies have linked to the reestablishment of a repressive chromatin
demonstrated that the 9-cis retinoic acid receptor (RXR) state. Recent cloning of the first mammalian histone
serves as a common heterodimeric partner for thyroid deacetylase represents a critical advance in under-
hormone receptor (TR), retinoic acid receptor (RAR), standing the dynamic interplay between chromatin re-
vitamin D receptor (VDR), and prostanoids (PPAR), as modeling factors and transcriptional control (Taunton
well as numerous orphan receptors (LeBlanc and Stun- et al., 1996). The identified protein, HDAC1, shows 60%
nenberg, 1995). identity to the S. cerevisiae transcriptional repressor
Transcriptional repression is an intrinsic part of endo- Rpd3p (Wolffe, 1996; Yang et al., 1996a). Genetic experi-
crine physiology and contributes to feedback regulation ments have demonstrated that Rpd3p interacts with
yeast Sin3p, which in turn is a negative regulator of
HO gene transcription (Sternberg et al., 1987). Recently,7These authors contributed equally to this work.
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Ayer et al. (1995) and Schreiber-Augus et al. (1995) de- Interaction between SMRT and mSin3A
To explore the possibility of the existence of an SMRTscribed the cloning of a mammalian homolog of SIN3
repressor complex that may involve mSin3A, severalthat functions as a transcription corepressor for the
protein-based interaction assays were utilized. TheMad±Max and Mxi±Max heterodimers. These observa-
yeast two-hybrid system was used to demonstrate func-tions led us to explore the possibility that the nuclear
tional association and to map the potential interfacereceptor corepressors SMRT/N-CoR mediate their tran-
between SMRT and mSin3A (Figure 1B). When fused toscriptional inhibitory effects by association with mSin3A,
mSin3A, the GAL4-activation domain (AD) gives a lowHDAC1, or both. Indeed, as described below, we provide
background-reporter activity (Figure 1B, lane 1). How-both biochemical and functional evidence that SMRT
ever, in the presence of the GAL4 DBD fusion to intactfunctions as an adapter to link RXR±TR and RXR±RAR
SMRT (GAL-SMRT), high reporter activity is observedheterodimers with mSin3A and HDAC1 to create a hor-
(lane 2), indicating a strong association between SMRTmone-sensitive multimeric repressor complex.
and mSin3A. Utilizing a series of deletion mutants, asso-
ciation with Sin3A was mapped to two regions of SMRT:
aa259±448, which correspond toSRD1, and aa 449±657,Results
which correspond to SRD2 (Figure 1B, lanes 4 and 5),
respectively. Consistent with the domain mapping, fur-SMRT Has Two Independent
ther deletions (aa 38±214, 38±266, and 336±370) com-Repressor Domains
pletely abolish association with mSin3A (data notWe have previously shown that the silencing activity of
shown).Therefore, these results suggest that the repres-SMRT resides in the N-terminal half (aa 1±981) of the
sor activities of SRD1 and SRD2 are likely to bemediatedprotein, while the receptor interaction domain (ID) is in
via association with mSin3A.the remaining C-terminal segment (Chen and Evans,
A reciprocal set of experiments was conducted utiliz-1995). To understand the mechanism of transcriptional
ing GAL DBD fusions of the SMRT repressor domain torepression and its molecular basis, we sought to identify
various deletions of mSin3A (Figure 1C). These experi-a minimal transferable repressor domain(s). SMRT con-
ments show that the amphipathic helix 1 (PAH1) ofstructs were generated by PCR amplification of the indi-
mSin3A mediates interaction with SMRT, while PAH2,cated regions and fused to GAL4 DNA binding domain
-3, or -4 alone show no autonomous association (data(DBD) 1±147 (Figure 1A). Repressor activity was deter-
not shown). Inclusion of PAH1 and -2 results in amined by transiently transfecting increasing amounts of
stronger association, while addition of PAH3 shows nothe GAL-fusion vectors along with a reporter construct,
additional benefit (Figure 1C, lanes 4, 5, 7, and 8). ThepMH100-TK-luc, which contains four GAL4 binding
strongest association is observed when all four PAHssites, into CV-1 cells. Fold repression was determined
are included (Figure 1C, lanes 10 and 11; data notrelative to the basal transcriptional activity of the re-
shown), which suggests that SMRT may make extensiveporter in the presence of GAL4 DBD alone. The results
contacts with mSin3A. This is in contrast to Mad/Mxi1,of this assay are summarized in Figure 1A. SMRT38±811
which selectively bind PAH2 via a 25 aa N-terminal seg-appears to be as potent a repressor (45-fold) as either
ment. We also examined whether the SMRT-related co-full-length SMRT (35-fold) or SMRT1±981 (30-fold), sug-
repressor, N-CoR, associates with mSin3A via SRD1-gesting that in fact it contains all the domains necessary
and SRD2-related regions. While the boundaries offor full repression. Additional nested C-terminal dele-
these regions have not been determined in detail, ourtions revealed a smaller though less potent repressor
results indicate that N-CoR also interacts with mSin3Adomain, SMRT38±448 (12-fold). Further C-terminal dele- (Figure 1C, lanes 3, 6, 9, and 12).
tions significantly lowered (38±370, 2.8-fold) and abol-
ished (38±266) repressor activity. N-terminal deletions
of SMRT38±448 revealed that theminimal repressor domain An SMRT±mSin3A±HDAC1 Ternary Complex
resides between amino acids 259 and 448 (12-fold re- To determine whether these interactions between SMRT
pression); further deletions abolished the repressor ac- and mSin3A are direct or not, GST-fusion proteins of
tivity (364±448). Thus, amino acids 259±448 define an SMRT38±266 and SMRT38±448 were made and tested in in
autonomous SMRT repressor domain (SRD1). The fact vitro-interaction assays (pull-down experiments) with
that this is a structural domain issupported by theobser- [35S]Methionine-labeled mSin3A. As shown in Figure 2A,
vation that there were several sites susceptible to prote- only GST-SMRT38±448 but not GST-SMRT38±266 or GST
ase digestion by bacterial proteases in the vicinity of alone pulls down radiolabeled mSin3A (Figure 2A, lanes
the boundaries of SRD1 (Figure 1A, arrows, and data 2, 3, and 4). These results suggest the existence of a
not shown). Expanding SRD1 toward the C-terminus direct physical interaction between SRD1 and mSin3A.
(259±811) yielded a construct with increased repressor Next, we compared mSin3A and -B for their ability to
activity (100-fold), suggesting the presence of a second interact with SRD1 in this interaction assay. As shown in
repressor domain. Additional deletions localized the Figure 2B (lanes 4±6), we failed to detect any interaction
boundary of a second autonomous minimal repressor between SMRT and mSin3B under conditions in which
domain between amino acids 559 and 657 (50-fold re- mSin3A shows strong association (Figure 2B, lanes 1±3).
pression), which is termed SRD2. SRD1 and SRD2 share This experiment suggests that there may be a marked
substantial homology with the comparable region in functional difference between the mSin3A and -B iso-
N-CoR (42% and 39%, respectively), suggesting func- forms. We next wished to determine which part of
mSin3A mediates the observed association with SRD1.tional conservation.
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Figure 1. Identification and Characterization of Repressor Domains in SMRT
(A) A schematic representation showing an alignment of SMRT and N-CoR and the boundaries of N- and C-terminal deletion mutants. Hatched
boxes indicate the previously identified repressor domains (RD1 and RD2) (HoÈ rlein et al., 1995), and the checkered boxes indicate the location
of receptor-interaction domains (ID1 and ID2) (Seol et al., 1996). Arrows indicate the location of bacterial protease-digestion sites in SMRT.
The GAL DBD1±147 (shaded ovals) was fused to the N-terminus of these constructs, and increasing amounts (0.02, 0.1, 0.5 mg) were tested in
transient transfection assays for repressor activity (percent of the basal activity in the presence of GAL DBD only). The minimal repressor
domains of SMRT (SRD1 and -2) are shaded. Repression values of 10-fold or higher are boxed.
(B) SMRT interacts with mSin3A in yeast. The indicated fragments of SMRT fused to GAL4 DNA binding domain (GAL4-SMRT) were cotrans-
formed with GAL4 activation domain fused to mSin3A (AD-mSin3A) into yeast cells. b-galactosidase activity from three independent trans-
formants was determined as described in the Experimental Procedures. Mean values of at least six independent measurements are presented.
Schematic representation of mSin3A with PAH domains (PAH1±4) are shown as boxes.
(C) mSin3A interaction with SMRT and N-CoR. C-terminal deletions of mSin3A were fused to the GAL4 activation domain and cotransformed
individually with either GAL4-SMRT (1±563) or GAL4-N-CoR (1016±1814) into yeast cells. b-galactosidase activity was determined as described
above. mSin3A1±192 contains PAH domain 1; mSin3A1±386 contains both PAH domains 1 and 2; mSin3A1±529 contains PAH domains 1, 2, and 3;
mSin3A1±965 contains all four PAH domains plus the conserved linker between PAH3 and -4.
When radiolabeled PAH1, PAH1±2, and PAH1±3 were pull-down experiments. Radiolabeled in vitro-translated
mSin3A PAH1±4 and SMRT were incubated with thetested in the same assay, no apparent interaction was
seen (Figure 2B, lanes 7±15), unlike in the yeast two- matrix in the presence or absence of 5 mM all-trans
retinoic acid (ATRA). Figure 2C shows that both mSin3Ahybrid experiment. However, when all PAH domains
(1±4) were included, strong interaction was observed PAH1±4 and SMRT are retained on the matrix in the
absence of ligand (Figure 2C, lanes 5 and 7) and are(Figure 2B, lanes 16±18).
Given that unliganded RAR±RXR heterodimers inter- released in a retinoic acid-dependent fashion (Figure
2C, compare lanes 5 and 6 and 7 and 8).act with SMRT and SMRT interacts with mSin3A, one
would predict that a hormone-sensitive complex of all Genetic studies from yeast suggest that Sin3p repres-
sion can function through an Rpd3p-dependent path-four proteins should form in vitro. To test this prediction,
an affinity matrix consisting of GST-tagged RXR and way (Stillman et al., 1994). In a companion paper, Hassig
et al. (1997 [this issue of Cell]) demonstrate that HDAC1,His-tagged RAR bound to glutathione beads was used in
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Figure 2. Direct Association between SMRT
and mSin3A
(A) mSin3A interacts with SMRT SRD1 in
vitro. In vitro-translated [35S]Methionine-
labeled mSin3A (lane 1) was incubated with
GST (G, lane 2), GST-SMRT38±266 (lane 3), or
GST-SMRT38±448 (lane 4). An asterisk indicates
the full-length radiolabeled protein in the in-
put lane (I).
(B) GST-SMRT38±448 binds the four paired
amphipathic helices of mSin3A. In vitro-
translated [35S]Methionine-labeled mSin3A,
mSin3B, and PAH domains of mSin3A
(PAH1 5 mSin3A112±192, PAH1±2 5mSin3A112±386,
PAH1±3 5 mSin3A112±529, PAH1±4 5
mSin3A112±965) were used as probes in GST
pull-down experiments as described above
with GST-SMRT38±448 (S) or GST (G). Asterisk
indicates the full-length radiolabeled protein
in the input lanes (I).
(C) SMRT and mSin3A associate with unli-
ganded RAR±RXR heterodimers in vitro. In
vitro-translated and [35S]Methionine-labeled
SMRT (lane 1) was incubated either with GST
(lane 3) or GST-RXR LBD/6His-RAR LBD het-
erodimer in the absence (lanes 3 and 5) or
presence (lane 6) of 5 mM ATRA. Radiola-
beled GAL4 DBD fusion of PAH1±4 of mSin3A (lane 2) was incubated either with GST (lane 4) or GST-RXR LBD/6His-RAR LBD heterodimer
and labeled SMRT (lanes 7 and 8) in the absence (lanes 4 and 7) or presence (lane 8) of 5 mM ATRA. The positions of SMRT and GAL4-Sin3A-
PAH1±4 are indicated on the left.
(D) SRD1 and SRD2 form a complex with mSin3A and HDAC1 in vitro. GST-SMRT38±448 (SRD1) and GST-SMRT548±811 (SRD2) were used as affinity
matrices for in vitro-cotranslated and [35S]Methionine-labeled mSin3A and HDAC1. The input lane (I) shows the radiolabeled proteins marked
on the right; GST was used as negative control (G).
the mammalian homolog of Rpd3p, forms a complex above basal strongly supports the contention that VP-
SMRT must be recruited to the promoter by HDAC1-with mSin3A. As shown in Figure 3D, using GST fusions
of SMRT38±448 and SMRT548±811, both SRD1 and SRD2 are GAL (Figure 3B). As shown in Figure 3C, cotransfection
of increasing amounts of full-length SMRT displaces theable to form ternary complexes with mSin3A and HDAC1
(Figure 3D, lanes 1 and 2). Interestingly, HDAC1 appears VP-SMRT activator and reestablishes repression to an
approximately 50% level (Figure 3C). As a control, co-to interact more strongly with the SRD1±mSin3A com-
plex than SRD2±mSin3A (Figure 3D, compare lanes 1 transfection of the C-terminal domain of SMRT fails to
squelch the VP-SMRT±HDAC1 interaction. In conclu-and 2). Together, these observations suggest that RAR±
RXR heterodimers are able to form a hormone-sensitive sion, our results demonstrate both direct and functional
association between HDAC1 and SMRT and the strongcomplex with SMRT, HDAC1, and mSin3A.
repressive function of a promoter-tethered histone
deacetylase.Functional Interaction between HDAC1
and SMRT
If HDAC1 is a mediator of SMRT silencing, then direct Retinoic Acid and Trichostatin A Synergize
in Cell Differentiationrecruitment of HDAC1 to a heterologous promoter
should result in repression of basal activity. We tested If HDAC is a critical component of receptor function,
then addition of a deacetylase inhibitor, such as Tricho-this prediction by fusing HDAC1 to the GAL4 DBD and
assayed its effect on the basal activity of the GAL4- statin A (TSA) (Taunton et al., 1996) would be expected
to relieve transcriptional repression, resulting in a pro-dependent reporter in transient transfection assays in
CV-1 cells. Figure 3A shows that HDAC1-GAL is a potent moter that is likely to be more sensitive to the addition
of hormone. We tested this prediction by studying therepressor of transcriptional activation, resulting in a 60-
fold repression of basal activity. We note here that simi- effect of TSA on the differentiation of myeloid leukemia
(HL-60) cells (Collins, 1987) following a high dose (100lar results were recently reported by Yang et al. (1996a)
using mammalian homologs of Rpd3p. To test whether nM) 9-cis RA treatment. A hallmark of this process is
the appearance of cell±surface differentiation markersHDAC1 and SMRT form a complex in mammalian cells,
a fusion of SMRT38±811 to the Herpes simplex virus VP16- CD14 and CD11b (Brackman et al., 1995). Cells were
treated with 9-cis RA, TSA, or both, and the expressionactivator domain was tested with HDAC1-GAL in a mam-
malian two-hybrid assay. Figure 3B shows that as in- of cell-surface antigens (CD11b and CD14) was moni-
tored by flow cytometry. TSA (100 nM) showed a minimalcreasing amounts of VP-SMRT are coexpressed with
HDAC1-GAL, the transcriptional activity of the re- effect on the CD14 marker, while a suboptimal dose (10
nM) of 9-cis RA resulted in modest stimulation (Figurepressed promoter increases dramatically, whereas VP-
SMRT alone has no effect on the reporter alone or coex- 4A). However, addition of both TSA and 10 nM 9-cis RA
resulted in dramatic enhancement of CD14 expressionpressed with GAL DBD (data not shown). Activation
Nuclear±Receptor Mediated Repression
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to levels higher than that following 100 nM 9-cis RA
treatment. Surprisingly, the high dose 9-cis RA treat-
ment was also enhanced by TSA. Similar results were
seen with the CD11b marker, although in this case low
doses of TSA partially activated gene expression (Figure
4B). Again, the combination of TSA and 9-cis RA proved
to be cooperative at both high and low doses. While
low levels of TSA were used to maintain dependence
on retinoids for differentiation, we cannot exclude a con-
tribution to CD14/CD11b expression by other deacety-
lase-sensitive factors. Nonetheless, this work supports
a role for histone deacetylase in nuclear receptor sig-
naling.
Discussion
A major question concerning nuclear receptor function
is to understand how nuclear receptors mediate activa-
tion and repression while remaining bound to DNA. A
considerable advance was made toward understanding
this when it was shown that ligand binding causes
the dissociation of corepressor proteins and promotes
association of coactivators. In this manuscript, we
describe the observation that the nuclear receptor
corepressor SMRT associates with both mSin3A and
HDAC1. This suggests that nuclear receptor cofactors
may function to remodel chromatin in a hormone-
dependent fashion. It also reveals a common pathway
for transcriptional repression by basic helix-loop-helix
leucine zipper proteins and nuclear receptors.
mSin3A is a homolog of the yeast HO gene repressor
Sin3p, first cloned by Sternberg et al. (1987) and subse-
quently shown to act through Rpd3p (Stillmann et al.,
1994). The discovery that HDAC1 is homologous to
Rpd3p provided a conceptual link between histone
deacetylation and transcriptional repression (Rundlett et
al., 1996; Taunton et al.,1996). The recent demonstration
that HDAC1 and mSin3A are present in the same protein
complexes in vivo and physically interact with each
other (Hassig et al., 1997), along with the data presented
in this work, suggests that a repressor complex is tar-
geted to a chromatin template by association with spe-
cific DNA-binding proteins. We demonstrate this in three
ways. First, the SMRT repression domains (SRD1 and
-2) are shown tocorrespond to mSin3A-interactionsites.
Second, in pull-down and yeast two-hybrid assays we
can demonstrate functional and physical interaction be-
tween SMRT and mSin3A, hormone-sensitive associa-
tion of receptor heterodimers, SMRT and mSin3A, and
Figure 3. SMRT and HDAC1 Interact In Vivo an in vitro ternary complex between SMRT, mSin3A, and
(A) DNA-bound HPAC1 is a repressor. Increasing amounts of HDAC1. Third, utilizing GAL DBD fusions, we demon-
HDAC1±GAL DBD were transiently cotransfected into CV-1 cells strate functional association of HDAC1 with SMRT in
with a reporter gene containing GAL4 binding sites upstream of a
transfected recipient cells.minimal TK promoter fused to luciferase gene (pMH100-TK-luc).
For nuclear receptors that remain bound to the tem-Normalized luciferase activity was determined, and fold repression
(relative to GAL DBD alone) calculated. plate in both the repressive and active state (Chen and
(B) VP-SMRT38±811 relieves HDAC1-dependent repression. Transient Evans, 1995; HoÈ rlein et al., 1995), it is necessary to
transfections were carried out as described above with a fixed (0.2
change coactivator composition without dissociation ofmg) amount of HDAC1±GAL DBD and increasing amounts of the VP
the regulatory complex. This property is uniquely sub-fusion of SMRT38±811.
(C) Full-length SMRT but not SMRT982±1495 squelches the relieving served by SMRT, which functions as a hormone-depen-
effect of VP-SMRT38±811 on HDAC1-dependent transcriptional repres- dent adaptor that associates both with mSin3 and
sion. Transient transfection assays were carried out with the indi-
HDAC1 through its repressor domain and with receptorscated amounts of HDAC1±GAL DBD and VP-SMRT38±811 in the pres-
via a distinct interaction domain. Thus, hormone-depen-ence of increasing amount of SMRT (full-length) or SMRT982±1495
expression vectors. dent dissociation of SMRTfrom an RXR±TR or RXR±RAR
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heterodimer will coordinately displace the mSin3A±
HDAC1 complex from a chromatin-bound template. Si-
multaneously, positive-acting cofactors with histone
acetylase activity will assemble on the template to pro-
mote chromatin remodeling. Even though there may be
multiple ways to control transcription, the regulation of
chromatin structure by opposing enzymatic activities
must be seen as central in this process. These results
suggest a simple binary paradigm (see Figure 4C) in
which hormones function via the targeting of histone-
modification machinery to disrupt nucleosome structure
(Fragoso et al., 1995; Bartsch et al., 1996).
Transcriptional repression was first described in the
TR and its oncogenic counterpart, v-erbA, and subse-
quently in the RARs (Damm et al., 1989; Sap et al., 1989).
This previous work revealed a role for repression as a
natural component of the hormone response and its
importance in transformation of leukemic cells (Damm
et al., 1987). Similarly, the oncogenic effects of the PML±
RAR-fusion protein in acute promyelocytic leukemia
(APL) are reversed by high dose RA therapy (Dyck et
al., 1994). We have previously demonstrated association
of PML-RAR with SMRT (D. Chen and R. M. E., unpub-
lished data) and thus presume that a deacetylase is
a component of this complex. Reciprocally, vitamin A
deficiency leads to a dramatic increased risk for squa-
mous and intestinal metaplasia (Hicks, 1983). Thus,
silencing mediators, when tethered to nonliganded nu-
clear receptors, function to oppose cellular differentia-
tion. In contrast, the association of mSin3 with the Mad±
Mxi1/Max heterodimers promotes differentiation. Myc,
which serves as a growth trigger, functions by displacing
Mad and its repressor from the template (Ayer et al.,
1995). Interestingly, retinoids promote differentiation of
myeloid leukemia (HL-60) cells by inhibiting myc gene
transcription and activating the expression of down-
stream target genes such as CD14 and CD11B (Collins,
1987). Thus, retinoic acid promotes both dissociation
of mSin3A and HDAC1 from retinoid receptors and asso-
ciation with Mad±Mxi1 growth inhibitors. Accordingly,
the mSin3A±HDAC1 complex appears to be a critical
component of the switch controlling cell-cycle regula-
tion and cancer.
Both mSin3A/B and SMRT/N-CoR were originally iso-
lated as cofactors mediating negative transcriptional
effects for bHLH-Zip proteins and nuclear receptors,
respectively. This work establishes a convergence ofFigure 4. The Histone Deacetylase Inhibitor Trichostatin A Potenti-
repression pathways and suggests that this type of reg-ates 9-cis Retinoic Acid-Induced Differentiation
ulation may be more widely conserved than previously(A) CD14 expression levels of HL-60 cells treated with the indicated
suspected. The demonstration that a common repressoramount of Trichostatin A (TSA) and 9-cis RA alone or in combination
were determined by flow cytometry as described in the Experimental complex may subserve multiple transcriptional regula-
Procedures. The mean fluorescence intensities (FL2) from a repre- tory pathways suggests that corepressors, like coacti-
sentative experiment are presented. vators, may function as integrators to control cell growth
(B) CD11bexpression levels of HL-60 cells treated with the indicated
and differentiation.amount of TSA or 9-cis RA alone or in combination were determined
by flow cytometry as described in the Experimental Procedures.
(C) Hormonal targeting of nuclear complexes to chromatin template.
Experimental ProceduresIn the absence of hormone, an SMRT±mSin3A±HDAC1 complex
associates with unliganded-receptor heterodimers. In this complex,
Plasmids, Transient Transfections, and Yeasthistone deacetylase activity creates a repressive chromatin envi-
Two-Hybrid Assayronment.
Mammalian expression vectors expressing SMRT, SMRT982±1495
(C-SMRT), SMRT1±981 (N-SMRT), GAL-SMRT, GAL-SMRT1±981, GAL-
SMRT982±1495, pCMX-GAL DBD, pCMX-VP16, and pMH100-TK-luc
were described previously (Chen and Evans, 1995). Plasmids were
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constructed by standard techniques. Detailed information is avail- virus promoter and remodels its nucleosome structure. Proc. Natl.
Acad. Sci. USA 93, 10741±10746.able upon request. CV-1 cells were transiently transfected as de-
scribed before (Chakravarti et al., 1996). Luciferase activity of each Brackman, D., Lund-Johansen, F., and Aarskog, D. (1995). Expres-
sample was normalized by the level of b-galactosidase activity. Each sion of cell surface antigens during the differentiation of HL-60 cells
transfection was carried out in triplicate and repeated 3±6 times. induced by 1,25-dihydroxyvitamin D3, retinoic acid and DMSO. Leu-
Yeast-transformation and b-galactosidase-activity assays were car- kemia Res. 19, 57±64.
ried out in strain Y190 according to the manufacturer's protocol
Brownell, J.E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D.G.,
(Clonetech).
Roth, S.Y., and Allis, C.D. (1996). Tetrahymena histone acetyltrans-
ferase A: a homolog to yeast Gcn5p linking histone acetylation to
In Vitro-Interaction Assays gene activation. Cell 84, 843±851.
GST-RXR LBD/6His RAR LBD was prepared from E. coli cells as Casanova, J., Helmer, E., Selmi-Ruby, S., Qi, J.S., Au-Fliegner, M.,
described elsewhere (Li et al., 1997) and purified by gel-filtration Desai-Yanjik, V., Koudinova, J., Yarm, F., Raaka, B.M., and Samuels,
chromatography through a Superdex S-200 column (Pharmacia). H.H. (1994). Functional evidence for ligand-dependent dissociation
GST-SMRT38±266, GST-SMRT38±448, and GST-SMRT548±811 were purified of thyroid hormone and retinoic acid receptors from an inhibitory
from E. coli cells, and extracts were passed through a glutathione- cellular factor. Mol. Cell. Biol. 14, 5756±5765.
Sepharose 4B affinity column (Pharmacia). Bound proteins were
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